Showing results (1-10 of 114) with videos related to
Sort By:
Pageof 12
Bulletin Du Cancer|November 6, 2007
[Angiogenesis targeting in renal carcinomas]Damien Pouessel, Stephane CulineOncology Reports|December 6, 2005
Phase II study of melphalan as a single-agent infused over a 24-hour period with individual adapted dosing in patients with recurrent epithelial ovarian cancerPhilippe Mougenot, Michel Fabbro, Françoise Bressolle, et al.Anticancer Research|August 21, 2003
Gemcitabine and docetaxel after failure of cisplatin-based chemotherapy in patients with carcinoma of unknown primary siteDamien Pouessel, Stephane Culine, Catherine Becht, et al.International Journal of Radiation Oncology, Biology, Physics|December 26, 2013
Combined chemoradiation therapy with twice-weekly gemcitabine and cisplatin for organ preservation in muscle-invasive bladder cancer: long-term results of a phase 1 trialDavid Azria, Olivier Riou, Xavier Rebillard, et al.Cancers|August 7, 2021
Survival of Patients with Epidermal Growth Factor Receptor-Mutated Metastatic Non-Small Cell Lung Cancer Treated beyond the Second Line in the Tyrosine Kinase Inhibitor EraValéry Refeno, Michele Lamuraglia, Safae Terrisse, et al.Seminars in Oncology|July 3, 2002
The present and future of combination chemotherapy in bladder cancerStephane CulineExpert Review of Anticancer Therapy|December 22, 2006
Targeted therapies in metastatic renal cell carcinoma: the light at the end of the tunnelDamien Pouessel, Stéphane CulineEuropean Urology|September 11, 2007
High frequency of intracerebral hemorrhage in metastatic renal carcinoma patients with brain metastases treated with tyrosine kinase inhibitors targeting the vascular endothelial growth factor receptorDamien Pouessel, Stéphane CulineAnti-Cancer Drugs|September 22, 2011
Complete clinical and biological response to zoledronic acid in castrate-resistant prostate cancer metastatic to boneDamien Pouessel, Stéphane CulineBulletin Du Cancer|November 14, 2008
[Towards the individualisation of prescriptions in oncology: urogenital cancers]Damien Pouessel, Stéphane CulinePageof 12